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Abstract
Cognitive deficits and reduced educational achievement are common in psychiatric illness; 
understanding the genetic basis of cognitive and educational deficits may be informative about the 
etiology of psychiatric disorders. A recent, large genomewide association study (GWAS) reported 
a genome-wide significant locus for years of education, which subsequently demonstrated 
association to general cognitive ability (“g”) in overlapping cohorts. The current study was 
designed to test whether GWAS hits for educational attainment are involved in general cognitive 
ability in an independent, large-scale collection of cohorts. Using cohorts in the Cognitive 
Genomics Consortium (COGENT; up to 20,495 healthy individuals), we examined the 
relationship between g and variants associated with educational attainment. We next conducted 
meta-analyses with 24,189 individuals with neurocognitive data from the educational attainment 
studies, and then with 53,188 largely independent individuals from a recent GWAS of cognition. 
A SNP (rs1906252) located at chromosome 6q16.1, previously associated with years of schooling, 
was significantly associated with g (P = 1.47×10−4) in COGENT. The first joint analysis of 43,381 
non-overlapping individuals for this a priori-designated locus was strongly significant (P = 
4.94×10−7), and the second joint analysis of 68,159 non-overlapping individuals was even more 
robust (P = 1.65×10−9). These results provide independent replication, in a large-scale dataset, of a 
genetic locus associated with cognitive function and education. As sample sizes grow, cognitive 
GWAS will identify increasing numbers of associated loci, as has been accomplished in other 
polygenic quantitative traits, which may be relevant to psychiatric illness.
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Introduction
A general cognitive ability factor (also termed g) typically captures just under half of the 
overall variance in performance on diverse laboratory measures of neurocognitive 
functioning.(Johnson et al., 2008) General performance on neurocognitive tests has 
remarkable predictive value across a diverse range of social, health and behavioral 
outcomes, more so than any other psychological trait.(Gottfredson, 1997; Deary et al., 2011; 
Deary, 2012) As examples, low g performance is associated with lower educational 
attainment and income,(Johnson et al., 2009) is a better predictor of mortality from 
cardiovascular disease than smoking, blood glucose and cholesterol,(Deary, 2008) and 
predicts longevity.(Batty et al., 2008) Deficits in general neurocognitive performance are 
pervasive in most psychiatric and neurologic disorders, yet are often the most difficult 
component to treat.(Millan et al., 2012) As such, understanding the neurobiology of human 
cognition is potentially critical to improving physical and mental health outcomes in society.
(Deary et al., 2010)
While both genetic background and environmental experience interact to shape cognitive 
development,(Deary et al., 2012) twin and family studies have consistently demonstrated 
heritability of more than 50% for general cognitive ability measured in adulthood.(Deary et 
al., 2009) Allelic variation can have a direct influence on brain biology by modifying the 
molecular structure and/or function of brain-expressed transcripts and proteins such as 
neurotransmitter receptors and neurodevelopmental growth factors.(Chen et al., 2004) 
However, attempts to pinpoint loci associated with human cognition across diverse 
population samples have proven challenging due to the difficulty of assembling the large 
cohorts required to detect small expected effects of individual variants in a highly polygenic 
trait.(Benyamin et al., 2014; Chabris et al., 2012; Luciano et al., 2011; Lencz et al., 2013; 
Need et al., 2009; Davies et al., 2011, 2015; Martin et al., 2011)
By contrast, educational history is easily obtainable demographic information collected in 
any field of medical research, and can therefore be collected in more readily across large 
cohorts as compared to cognition. Educational attainment, as measured by self-reported 
years of schooling, has been proposed as a ‘proxy phenotype’ for cognitive ability for 
GWAS since much larger samples can be utilized compared to neurocognitive studies.
(Rietveld et al., 2014a, 2014b, 2013; Martin et al., 2011) The Social Science Genetic 
Association Consortium (SSGAC) reported on a 126,559 person GWAS that detected three 
genome-wide significant SNPs associated with completion of college (rs11584700 and 
rs4851266) and years of schooling (rs9320913).(Rietveld et al., 2013) In a post hoc analysis, 
these SNPs had a stronger and more direct effect on cognitive function than on education.
(Rietveld et al., 2013) Further, a polygenic risk score of educational attainment SNPs 
accounted for 2-3% of the variance in general cognitive ability an in independent sample, 
and a mediation analysis suggested that g mediated more than half of the effect these SNPs 
had on education.(Rietveld et al., 2013) Here, we analyzed the three SNPs obtained in the 
SSGAC educational attainment GWAS in ≈20,000 independent subjects in the Cognitive 
Genomics Consortium (COGENT),(Donohoe et al., 2012; Lencz et al., 2013) and found 
converging evidence across multiple large cohorts that common variation at genomic region 
6q16.1, previously associated with years of schooling, reliably predicts variation in g.
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Methods and Materials
COGENT is an international GWAS collaboration formed to conduct genetic analyses of g 
and related neurocognitive processes in healthy individuals.(Donohoe et al., 2012) Though 
common GWAS markers have been proposed to account for ~30% or more of the variance 
in general intelligence in adults, individual SNPs only contribute a small fraction of the 
variance to the heritability of g due to extreme polygenicity.(Davies et al., 2011; Marioni et 
al., 2014) Detecting SNP associations of such small magnitudes via GWAS requires large 
samples many times the size an individual lab can ascertain, leading to consortia such as 
COGENT. The decision to study g in COGENT stemmed from longstanding evidence that a 
g factor can be derived consistently, captures almost half the variance in overall test 
performance, and is relatively invariant to the neurocognitive test battery used and specific 
abilities assessed.(Johnson et al., 2008; Panizzon et al., 2014)
The first phase of COGENT (‘COGENT1’) resulted in a GWAS of general cognitive ability 
in ≈5,000 individuals from the general population.(Lencz et al., 2013) The next (and 
ongoing) wave of data collection in COGENT (‘COGENT2’) has resulted in the acquisition 
of ≈15,000 independent subjects with neurocognitive and GWAS data for analysis (see 
Table 1 for cohort details). To be included as a participant in COGENT, data from at least 
one neuropsychological measure across at least three domains of cognitive performance 
(e.g., digit span for working memory; logical memory for verbal declarative memory; and 
digit symbol coding for processing speed), or the use of a validated g-sensitive measure was 
required. Tests missing for more than 5% of the sample in an individual study were 
excluded. Each COGENT study administered an average of 10.3 neurocognitive tests, and 
the internal consistency of performance within each study was strong (mean Cronbach's 
alpha = 75%; supplementary table S1). The first unrotated principal component accounted 
for just under half of the variance across the 21 studies on average, as expected based on an 
extensive prior literature.(Carroll, 1993) As Figure 1 shows, g had normal distributional 
properties within all 21 studies, a feature critical to enhancing statistical power in 
quantitative trait analysis.
All COGENT samples were genotyped on commercial Illumina or Affymetrix genome-wide 
SNP microarrays (supplementary table S1). Standard GWAS quality control (QC) methods 
were applied to the genetic data (described in detail in the supplementary information). 
Subjects in the study were Caucasian of European ancestry, which we confirmed by analysis 
of genotype data using multidimensional scaling (MDS). Genetic outliers were removed in 
each study based on MDS axis plotting versus HapMap3 ethnic subgroups. Note that none 
of the three SNPs previously associated with education were variants included on 
commercially available microarrays, and thus were imputed into their datasets.(Rietveld et 
al., 2013) In the COGENT1 studies, SNPs were imputed using HapMap3 reference panels as 
previously described.(Lencz et al., 2013) COGENT2 samples that did not have genotypes 
for the SNPs of interest were imputed using IMPUTE2(Howie et al., 2009) and 1000 
Genomes Project reference panels (downloaded June 2014).
SNP analysis of g was completed separately within each COGENT study using 
Plink(Purcell et al., 2007) or Genome-wide Complex Trait Analysis (GCTA).(Yang et al., 
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2011) Plink was used to analyze datasets comprising unrelated individuals, and GCTA used 
to analyze five datasets in which multiple family members were known to be included a 
priori. GCTA has implemented a mixed-linear-model association (MLMA) analytic 
function that corrects for population or relatedness structure through a correction that is 
specific to the structure of interest.(Yang et al., 2014) Regression coefficients and standard 
error estimates were generated within each study and then carried forward for meta-analysis 
using Metasoft(Han and Eskin, 2011) and the R MetABEL package(Aulchenko et al., 2007) 
for plotting of results. Although we expected that allelic effects for cognitive ability would 
mirror the direction observed for educational attainment, all analyses were conservatively 
carried out using two-tailed tests.
A multi-stage approach was utilized to determine if GWAS hits associated with educational 
attainment were also associated with general cognitive ability in COGENT. First, we 
examined the p-values of the three educational attainment SNPs (and their close proxies) in 
the database housing the results of the COGENT1 GWAS.(Lencz et al., 2013) SNPs with p-
values < .05 identified in this first stage were then meta-analyzed for association to g in 
≈16,000 independent subjects in the subsequent replication stage.
Results
COGENT Analysis
Using the approach described above, the two SNPs previously associated with the 
dichotomous variable of completing college (rs11584700 and rs4851266) in(Rietveld et al., 
2013) were not significantly associated with g in COGENT1 (P's > .05). The third SNP 
(rs9320913) associated with years of schooling was neither genotyped nor imputed in 
COGENT1; however, a close proxy SNP (rs1906252, R2 = 1.0 in HapMap2 CEU, R2 = .905 
in 1000 Genomes CEU) was available for analysis in the COGENT1 GWAS data. 
rs1906252 was either typed or imputed in all nine COGENT1 studies, and was significantly 
associated with general cognitive ability in the expected direction, such that the minor (A) 
allele was associated with higher g scores (β = .050, P = 1.20 × 10−2; PQ = .340). This SNP 
was therefore carried forward for analysis in COGENT2.
To date, GWAS and neurocognitive data have been acquired for more than 15,000 
participants from 12 independent cohorts in COGENT2. The average sample size of 
individual COGENT2 studies was 1,398 and ranged from 127 to 4,412 Caucasian subjects 
of European ancestry. rs1906252 was genotyped or imputed in all 12 COGENT2 samples (N 
= 16,544 genotypes), of which 15,533 had g factor data. As shown in Table 2, the 
association between allelic variation at SNP rs1906252 and g in COGENT2 was statistically 
significant and not biased by heterogeneity (β = .027, P = 2.34 × 10−3, two-tailed; PQ = .
671). The direction of the minor allele effect was positive in 10 out of 12 COGENT2 
studies, which was consistent with the educational attainment GWAS studies and 
COGENT1, and statistically different from chance (binomial test, P = .02). Finally, all 21 
COGENT datasets were merged to analyze the association between rs1906252 and g in the 
combined sample of 20,495 individuals. A significant association was again detected in the 
combined analysis that was not confounded by heterogeneity (β = .031, P = 1.47 × 10−4, 
two-tailed; PQ = .543). Figure 2 presents the combined results in a forest plot, and as shown 
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in Figure 3, a linear increase in general cognitive ability was related positively to minor A 
allele load.
We tested the robustness of the association between rs1906252 and g in a series of 
sensitivity analyses. First, a potential confound worthy of consideration was the fact that two 
COGENT1 studies (Helsinki Birth Cohort Study [HBCS; n = 332] and the 1936 Lothian 
Birth Cohort Study [LBC1936; n = 1,005])(Lencz et al., 2013) were also included in 
SSGAC.(Rietveld et al., 2014b, 2013) The non-independence of our collective studies and 
the high correlation between educational attainment and cognition necessitated a sensitivity 
analysis requiring HBCS and LBC1936 be excluded and the remaining COGENT studies 
reanalyzed. This analysis also yielded a significant result between variation in rs1906252 
and g (β = .026, P = 1.60 × 10−3, two-tailed; PQ = .889; see Table 2).
Next, age had a bimodal distribution across the 21 COGENT studies. The first peak was at 
approximately 18 years of age, and the second peak at approximately 70 years 
(supplemental figure S1). To explore the effect of age on the association between rs1906252 
and g across the lifespan, we examined the interaction between rs1906252 and age on g, 
which was not significant (β = .0004, P = .302). We then split the sample at the ‘valley’ of 
the distribution at age 40. This resulted in a group of 7,208 individuals under 40 years of age 
and a group of 13,287 individuals 40 years of age or older. The interaction between 
rs1906252 and this dichotomous age split was not significant (β = .007, P = .728). Thus, age 
did not moderate the association between rs1906252 and general cognitive function across 
the lifespan in COGENT.
SSGAC Meta-Analysis
The SSGAC reanalyzed their GWAS data utilizing a two-stage design in order to examine 
whether educational attainment is a valid proxy phenotype for cognitive ability.(Rietveld et 
al., 2014b) Subjects with available neurocognitive data (n = 24,189) were removed from the 
larger cohort, and a GWAS of years of education was then conducted in the remaining 
~106K participants (Stage 1). The top 69 SNPs associated with educational attainment were 
then carried forward for analysis in relation to cognitive performance in the ~24K subsample 
(Stage 2). In Stage 1, the chromosome 6q16.1 locus previously associated with years of 
schooling was again genome-wide significant for educational attainment, although the top 
SNP at this locus was slightly different (rs9320913 in the original GWAS and rs1487441 in 
the second GWAS; R2 > .9 between the two SNPs). In Stage 2, rs1487441 was the SNP 
most strongly associated with cognitive performance (P = 1.24 × 10−4).
Notably, rs1487441 is a perfect proxy for our SNP, rs1906252 (R2 = 1 in both HapMap and 
1000 Genomes). Thus, we sought to integrate our current results with the most recent 
SSGAC findings. As shown in Table 3, we performed a meta-analysis of the SSGAC 
cognitive subcohort with our fully independent COGENT cohorts. LBC1936 and HBCS 
were part of the SSGAC studies, so they were excluded for this particular analysis. 
However, this was a conservative approach since (i) LBC1936 was included in the cognitive 
performance sample as part of the Childhood Intelligence Consortium, which used age 11 
cognitive phenotypes for LBC1936, whereas LBC1936 adult phenotypes were included in 
COGENT; and (ii) HBCS was not included in the SSGAC cognitive analysis, only the 
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educational attainment GWAS.(Rietveld et al., 2014b) With a total sample size of 43,381 
non-duplicated individuals across SSGAC and COGENT, the association between this locus 
and g had an estimated effect size of β = .031 (P = 4.94 × 10−7).
CHARGE Meta-Analysis
A GWAS of general cognitive function that included ≈53,000 individuals from 31 
population-based cohorts was recently published by the Cohorts for Heart and Aging 
Research in Genomic Epidemiology (CHARGE) consortium.(Davies et al., 2015) The study 
reported genome-wide significant SNP associations with general cognitive ability in three 
genomic regions, including rs1906252 (P = 1.55 × 10−8). We sought to integrate the 
COGENT findings with the CHARGE findings as well, and conducted a second meta-
analysis of rs1906252 and g. In this analytic series, the COGENT samples were fully 
independent from both the SSGAC and the CHARGE samples. In other words, we excluded 
HBCS and LBC1936 as above, and excluded additional data from our Framingham Heart 
Study, Second Generation Cohort (FHS) sample, the Cardiovascular Health Study (CHS) 
sample, and the Norwegian Cognitive NeuroGenetics (NCNG) sample, all of which 
overlapped with CHARGE to some extent. In the reduced COGENT sample of 16 sites and 
≈15,000 subjects fully independent from SSGAC and CHARGE, rs1906252 retained a 
significant association to g (β = .022, P = 2.81 × 10−2). Further, the joint analysis of the 42 
independent COGENT and CHARGE cohorts (N ≈ 68,000) was robust (β = .029, P = 1.65 
× 10−9).
Conclusions
The current study identified a significant association of a SNP at chromosome 6q16.1 with 
general cognitive ability across 21 well-characterized international samples of European-
ancestry individuals from the general population. Sensitivity analysis suggested that the 
association between rs1906252 and g was significant, independent of the previously 
published cohorts from the educational attainment GWAS; moreover, the strength of the 
association was not affected by age of the subjects. In COGENT, the direction of association 
with g was consistent with the association to self-reported educational attainment in the 
SSGAC, with more copies of the minor A allele linked to better performance on objectively-
measured sub-traits that comprise general cognitive ability.
Based on the commonly used formula,(Thorleifsson et al., 2009) R2 = 2f(1-f)a2, where f is 
the allele frequency (0.47 in this instance) and a is the additive effect as measured by 
standardized beta, the independent COGENT cohort produces an estimated effect size of R2 
= .0382% (Table 3). This effect size estimate is slightly more than half the value obtained in 
the SSGAC cognitive subcohort. This is probably due, at least in part, to the ‘winner's curse’ 
phenomenon in which initial observations produce inflated effects by chance.(Zollner and 
Pritchard, 2007). The present report provides the first estimate of the effect size that is fully 
independent of the initial discovery cohort. This effect size is approximately an order of 
magnitude smaller than the largest allelic effect sizes observed for other complex polygenic 
traits such as height or weight (Visscher et al, 2012; Wood et al, 2014), possibly due to the 
inherent noise and heterogeneity in the construction of the g phenotype. However, the 
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success of GWAS for height and weight provide optimism that future, larger GWAS of 
cognitive ability will prove increasingly successful at identifying significant associations.
For example, the first study reporting a genome-wide significant QTL for height(Weedon et 
al., 2007) had power of only 3.2% to detect the HMGA2 locus, based on the effect size 
estimate later derived from an independent cohort that was an order of magnitude larger.
(Lango Allen et al., 2010) Similarly, subsequent height GWAS(Weedon et al., 2008) 
remained underpowered by conventional criteria (1-β = .80) to detect even the strongest loci, 
yet were still able to obtain genome-wide significance for multiple loci, including those for 
which power was <1%. This pattern applies to all polygenic complex traits, due to the very 
large number of loci that are available to be detected, especially given that the number of 
associated loci tends to increase very rapidly as effect sizes drop.(Park et al., 2010)
Functionally, rs1906252 is about 700 kilobases from the nearest annotated gene, but it is in 
an intron of a long intergenic non-coding RNA (lincRNA; transcript ID: RP11-436D23.1; 
Gene ID: LOC101927335; Ensembl Gene ID: ENSG00000271860) that is expressed in 
human brain tissue based on searches in BrainSpan (http://www.brainspan.org/) and 
GeneProf(Halbritter et al., 2012) (http://www.geneprof.org/). In order to identify potential 
regulatory elements at this genomic locus, we interrogated rs1906252 using HaploReg v3 
(Ward and Kellis, 2012). While rs1906252 is unannotated, it is in nearly perfect LD (R2 = .
99) with rs77910749, which is highly conserved (by both GERP and SiPhy computations), is 
a DNase hypersensitivity site in fetal brain, and serves as a weak enhancer or transcription 
start site across multiple brain tissues. Notably, rs1906252 was recently reported to be a 
genome-wide significant variant associated with bipolar disorder,(Mühleisen et al., 2014) 
again providing evidence of the important overlap of general cognitive ability and 
psychiatric illness; the primary finding of our previous COGENT study was a significant 
polygenic overlap between SNPs for general cognitive ability and schizophrenia.(Lencz et 
al., 2013) Additionally, rs1906252 was among the top findings (though not significant after 
correction for multiple comparisons) in an earlier GWAS of processing speed based on 
performance on the symbol search test conducted in part in the LBC1936 cohort.(Luciano et 
al., 2011) Most recently, rs1906252 and 10 other SNPs in this region were associated with 
general cognitive function in a GWAS of ≈53,000 subjects at a threshold considered to 
reach genome-wide significance.(Davies et al., 2015)
In summary, the current study provides an independent replication of a link between genetic 
variation at rs1906252 and neurocognitive ability. Results also provide evidence that the 
proxy phenotype approach of using educational attainment as an indirect measure of 
cognitive ability for GWAS has external validity.
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Figure 1. 
Kernel density plot (KDP) of the g factor across 21 COGENT studies. Each g score is 
smoothed for each individual using a strongly peaked kernel function in order to evaluate 
every point along the x-axis. The y-axis represents density. As can be seen, the shape of the 
distribution tightly fits a Gaussian curve across all studies.
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Figure 2. 
Results (in forest-plot format) of the meta-analysis between rs1906252 and general cognitive 
ability in all 21 COGENT studies. A positive effect was detected in 17 out of 21 studies.
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Figure 3. 
Effect plot of the association between rs1906252 and general cognitive ability. A linear 
increase in general cognitive ability was related positively to minor A allele load. In the 
combined sample, 5,254 subjects had no copies of the minor allele, 10,329 subjects were 
heterozygous, and 4,912 subjects had two copies of the minor A allele.
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Table 1
Sites and basic demographics of samples included in the Cognitive Genomics Consortium (COGENT; ordered 
alphabetically).
Study Study Name N Age (mean) Age range % Male
ADNI1 Alzheimer's Disease Neuroimaging Initiative, Phase 1 127 75.7 62-90 55.9
CHS Cardiovascular Health Study 2,114 77.9 69-99 37.1
DNS Duke Neurogenetics Study 357 19.7 18-22 47.6
FHS Framingham Heart Study, Second Generation Cohort 1,650 65.3 38-90 45.6
GCAP NIMH Genes, Cognition and Psychosis Program 655 31.5 18-60 46.9
GenADA Genotype-Phenotype Associations in Alzheimer's Disease 782 73.4 48-94 35.7
HBCS Helsinki Birth Cohort Study 332 67.7 64-75 100.0
IBG Institute for Behavioral Genetics 299 15.9 12-19 78.6
LBC1936 Lothian Birth Cohort 1936 1,005 69.6 68-71 50.6
LLFS Long Life Family Study 3,606 64.6 24-89 45.2
LOAD Late Onset Alzheimer's Disease Family Study 1,141 75.1 53-98 36.6
LOGOS Learning on Genetics of Schizophrenia Spectrum 864 22.5 18-44 100.0
MAN Manchester Longitudinal Studies of Cognitive Aging 805 67.2 45-87 28.9
MUC1 Munich, Germany Sample 1 588 50.5 19-79 50.0
MUC2 Munich, Germany Sample 2 538 45.1 19-72 45.7
NCNG Norwegian Cognitive NeuroGenetics 670 47.6 18-79 31.9
NEW Newcastle Longitudinal Studies of Cognitive Aging 753 67.0 54-87 29.0
PING Pediatric Imaging, Neurocognition and Genetics Study 637 11.6 3-18 52.4
PNC Philadelphia Neurodevelopmental Cohort 4,412 13.8 8-21 50.2
TOP Thematic Organized Psychosis Research Study 394 34.6 17-55 49.2
ZHH Zucker Hillside Hospital 219 35.3 8-78 49.3
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Table 3
Meta-analytic results of the association between general cognitive ability and genetic variants in chromosome 
6q16.1 associated with educational attainment in COGENT (SNP rs1906252), SSGAC (SNP rs1487441) and 
CHARGE (SNP rs1906252).
Consortium N studies N subjects β S.E. P
COGENT, excluding HBCS and LBC1936 19 19,192 .026 .008 1.60E-03
SSGAC 11 24,189 .036 .009 1.24E-04
COGENT and SSGAC 30 43,381 .031 .006 4.94E-07
COGENT, excluding HBCS, LBC1936, CHS, FHS and NCNG 16 14,971 .022 .010 2.81E-02
CHARGE 26 53,188 .031 .006 1.55E-08
COGENT and CHARGE 42 68,159 .029 .005 1.65E-09
Abbreviations: COGENT, Cognitive Genomics Consortium; SSGAC, Social Science Genetic Association Consortium; CHARGE, Cohorts for 
Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium. Note: COGENT studies that overlapped with SSGAC (HBCS and 
LBC1936) and/or CHARGE (HBCS, LBC1936, CHS, FHS, and NCNG) were removed prior to conducting joint analyses. The Lothian Birth 
Cohort Studies of 1921 and 1936 and the Helsinki Birth Cohort Study (HBCS) overlapped between SSGAC and CHARGE.
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